Acute myeloid leukemia (AML) is a rare disease that is seen most often in older adults, although it can occur in younger people as well. This webinar discusses the symptoms of AML, how it is diagnosed, risk factors for developing AML, and current treatment options.

Maintenance therapy after a stem cell transplant is used to decrease early death, increase time to progression and improve the quality of life in patients with multiple myeloma. Dr. Callander provides an overview of the history of maintenance therapy and discusses the new and exciting treatment options available. She also delves into potential future therapies that are currently under study.

Un trasplante que utiliza las propias células madre del paciente (trasplante autólogo de células madre) o la terapia de células CAR T son opciones de tratamiento para pacientes con ciertos tipos de linfoma.

Acute myeloid leukemia is a fast-moving cancer that can be fatal in weeks or months without treatment. This presentation reviews the causes, symptoms, and treatments for AML and recent progress in cure rates or prolonged remission for an increasing number of patients.

Myelodysplastic syndrome (MDS) is a blood disorder that can develop into leukemia. There are several treatments for MDS, including stem cell transplantation. This presentation reviews key features of MDS, treatment options and when a transplant is an appropriate remedy.

A menudo se utiliza un trasplante de células madre para tratar a pacientes con mieloma múltiple. La terapia de mantenimiento después del trasplante puede prolongar la remisión y prolongar la vida del paciente.

Descubra que se sabe actualmente sobre el valor del tratamiento adicional o "terapia de mantenimiento" después de un trasplante de células madre para la leucemia mieloide aguda (LMA).